rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Justin W. Yorke

Director

Company insider

Files Form 4 as: Director, Processa Pharmaceuticals; Director, Splash Beverage Group, Inc. (NV); Director, Las Vegas Railway Express; CEO, JMG Exploration.

Every Form 4 they filed

In numbers

Trades disclosed
50
Buys
2
Sells
5
Bought
$31K
Sold
$208K
Companies
4
Companies where not an officer
3
First trade
23 Sep 2008
Last trade
26 Jul 2026
Last filed
28 Jul 2026

Companies traded

Where they are an officer
JMG ExplorationOfficer · last 26 Jan 20100 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PCSA Processa PharmaceuticalsDirector · Biotechnology · last 26 Jul 20262 buys · 5 sells
Splash Beverage Group, Inc. (NV)Director · Beverages · last 31 Jul 20250 buys · 0 sells
Las Vegas Railway ExpressDirector · last 26 Jan 20110 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Jul 2026filed 28 Jul 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—33,500 at $0.00filing
26 Jul 2026filed 28 Jul 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—33,500 at $0.00filing
26 Jun 2026filed 30 Jun 2026PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code M—203filing
26 Jun 2026filed 30 Jun 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—203 at $0.00filing
26 Jun 2026filed 30 Jun 2026PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—203 at $0.00filing
26 Jun 2026filed 30 Jun 2026PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code M—203filing
1 Oct 2025filed 3 Oct 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
1 Oct 2025filed 3 Oct 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—300,000 at $0.00filing
31 Jul 2025filed 15 Oct 2025Splash Beverage Group, Inc. (NV)option or derivative · BeveragesSEC FORM 4 Code A—750,000filing
24 Jul 2025filed 28 Jul 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—175,299 at $0.00filing
29 Jan 2025filed 18 Feb 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—12,400 at $0.00filing
29 Jan 2025filed 18 Feb 2025PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—6,200 at $0.00filing
27 Jan 2025filed 31 Jan 2025PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Bought$9,92012,400 at $0.80filing
3 Sep 2024filed 18 Sep 2024PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—31,206 at $0.00filing
30 Jan 2024filed 31 Jan 2024PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Bought$22K8,000 at $2.69filing
21 Nov 2023filed 28 Nov 2023PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code J—55,267 at $0.00filing
12 Oct 2023filed 23 Oct 2023PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code A$1,8006,000 at $0.30filing
12 Oct 2023filed 12 Oct 2023PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code A$1,8006,000 at $0.30filing
10 Oct 2023filed 10 Oct 2023PCSA Processa PharmaceuticalsBiotechnologySEC FORM 4 Code A$2,52012,000 at $0.21filing
27 Jun 2023filed 24 Jul 2023PCSA Processa Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—23,636 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care7

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.